losartan has been researched along with Abnormalities, Drug-Induced in 6 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with Losartan resulted in severe renal abnormalities." | 5.35 | Inhibition of Angiotensin II receptors during pregnancy induces malformations in developing rat kidney. ( Ciuffo, GM; Forneris, ML; Fuentes, LB; Sánchez, SI; Seltzer, AM, 2008) |
| " The mother suffered from essential hypertension and was treated with Cozaar (losartan 50 mg)." | 3.73 | Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists. ( Daïkha-Dahmane, F; Jugie, M; Lenclen, R; Levy-Beff, E, 2006) |
| "Treatment with Losartan resulted in severe renal abnormalities." | 1.35 | Inhibition of Angiotensin II receptors during pregnancy induces malformations in developing rat kidney. ( Ciuffo, GM; Forneris, ML; Fuentes, LB; Sánchez, SI; Seltzer, AM, 2008) |
| "Losartan is a specific angiotensin II receptor antagonist." | 1.32 | Losartan induced fetal toxicity. ( Aggarwal, R; Malhotra, N; Nayar, B; Singhal, A, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gersak, K | 1 |
| Cvijic, M | 1 |
| Cerar, LK | 1 |
| Nayar, B | 1 |
| Singhal, A | 1 |
| Aggarwal, R | 1 |
| Malhotra, N | 1 |
| Daïkha-Dahmane, F | 2 |
| Levy-Beff, E | 1 |
| Jugie, M | 1 |
| Lenclen, R | 1 |
| Sánchez, SI | 1 |
| Seltzer, AM | 1 |
| Fuentes, LB | 1 |
| Forneris, ML | 1 |
| Ciuffo, GM | 1 |
| Lambot, MA | 1 |
| Vermeylen, D | 1 |
| Noël, JC | 1 |
| Martinovic, J | 1 |
| Benachi, A | 1 |
| Laurent, N | 1 |
| Gubler, MC | 1 |
6 other studies available for losartan and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Angiotensin II receptor blockers in pregnancy: a report of five cases.
Topics: Abnormalities, Drug-Induced; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphe | 2009 |
Losartan induced fetal toxicity.
Topics: Abnormalities, Drug-Induced; Antihypertensive Agents; Female; Fetal Death; Heart Defects, Congenital | 2003 |
Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists.
Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II Type 1 Receptor Blockers; Diseases in Twins; Fema | 2006 |
Inhibition of Angiotensin II receptors during pregnancy induces malformations in developing rat kidney.
Topics: Abnormalities, Drug-Induced; Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiote | 2008 |
Angiotensin-II-receptor inhibitors in pregnancy.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Antihypertensive Agents; Cesarean Secti | 2001 |
Fetal toxic effects and angiotensin-II-receptor antagonists.
Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensi | 2001 |